NASDAQ: ARTVArtiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?
Insider buying vs selling
Have Artiva Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Subhashis Banerjee | Med | 2026-11-02 | 1,110 | $4.18 | $4.64kSell |
| Christopher Horan | CTO | 2026-11-02 | 10,423 | $4.18 | $43.58kSell |
| Jennifer Bush | COO;CLO | 2026-11-02 | 8,439 | $4.18 | $35.28kSell |
| Fred Aslan | CEO | 2026-11-02 | 62,178 | $4.18 | $259.97kSell |
| Fred Aslan | CEO | 2026-10-06 | 23,463 | $7.20 | $168.89kSell |
| Jennifer Bush | COO;CLO | 2026-10-05 | 8,370 | $6.84 | $57.23kSell |
| Christopher Horan | CTO | 2026-10-05 | 10,340 | $6.84 | $70.69kSell |
| Subhashis Banerjee | Med | 2026-10-05 | 1,099 | $6.84 | $7.51kSell |
| Fred Aslan | CEO | 2026-10-05 | 61,696 | $6.84 | $421.82kSell |
| Fred Aslan | CEO | 2026-09-08 | 23,429 | $10.92 | $255.75kSell |
ARTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARTV insiders and whales buy or sell their stock.
ARTV Shareholders
What type of owners hold Artiva Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gc Corp | 12.27% | 5,999,703 | $25.14M | Insider |
| Yongjun Huh | 10.06% | 4,916,249 | $20.60M | Insider |
| 5am Partners VI LLC | 4.81% | 2,353,304 | $9.86M | Insider |
| Venbio Global Strategic Fund III LP | 3.96% | 1,936,637 | $8.11M | Insider |
| Fred Aslan | 2.98% | 1,457,428 | $6.11M | Insider |
| Jennifer Bush | 0.73% | 357,720 | $1.50M | Insider |
| Christopher Horan | 0.62% | 302,321 | $1.27M | Insider |
| Thad Allen Huston | 0.45% | 220,000 | $921.80k | Insider |
| Wellington Biomedical Innovation Master Investors Cayman I LP | 0.40% | 194,108 | $813.31k | Insider |
| Subhashis Banerjee | 0.35% | 168,738 | $707.01k | Insider |
ARTV vs Biotech Stocks
Artiva Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.